Pregled bibliografske jedinice broj: 827662
Impact of chronic bronchial infection on the lungs and beyond
Impact of chronic bronchial infection on the lungs and beyond // European Respiratory Monograph / Welte, Tobias ; Blasi, Francesco ; Miravitlles, Marc (ur.).
Norwich: European Respiratory Society, 2013. str. 46-57
CROSBI ID: 827662 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Impact of chronic bronchial infection on the lungs and beyond
Autori
Matkovic, Zinka ; Tudoric, Neven ; Miravitlles, Marc
Vrsta, podvrsta i kategorija rada
Poglavlja u knjigama, znanstveni
Knjiga
European Respiratory Monograph
Urednik/ci
Welte, Tobias ; Blasi, Francesco ; Miravitlles, Marc
Izdavač
European Respiratory Society
Grad
Norwich
Godina
2013
Raspon stranica
46-57
ISBN
978-1-84984-034-7
Ključne riječi
chronic obstructive pulmonary disease, colonisation, comorbidities, exacerbation, infection, inflammation
Sažetak
Impaired host defences in chronic bronchial diseases allow the establishment and proliferation of potentially pathogenic microorganisms (PPMs). This is particularly frequent in patients with chronic obstructive pulmonary disease (COPD). Repeated isolation of PPMs in bronchial secretions in stable patients was defined as colonisation ; however, it is well documented that the presence of PPMs in the lower airways is associated with increased exacerbation frequency and severity, faster lung function decline and worse health status. Therefore, the term chronic bronchial infection (CBI) has been proposed to define this clinical situation. The presence of CBI in COPD is characterised by increased chronic inflammation not only in the airways and lung parenchyma, but also at a systemic level. Current evidence indicates that a significant amount of local and systemic inflammatory response in COPD may be attributable to the presence of PPMs. Since atherosclerosis is also characterised by chronic inflammation and oxidative stress, it has been hypothesised that CBI may be responsible for some extrapulmonary manifestations of COPD, particularly the high prevalence of cardiovascular comorbidities.
Izvorni jezik
Engleski